StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.45+0.30 (+13.95%)

Close on Nov 17, 2026Market cap $106.08MP/E –Yield –

NRX Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

NRX Pharmaceuticals's cash was $26.69M at Jun 30, 2026. For fiscal 2025 it was $7.80M, up 440.3% from the year before. The highest annual figure on record is $27.61M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.80M+440.3%
FY2024Dec 31, 2024$1.44M-68.6%
FY2023Dec 31, 2023$4.60M-77.1%
FY2022Dec 31, 2022$20.05M-27.4%
FY2021Dec 31, 2021$27.61M+1384.9%
FY2020Dec 31, 2020$1.86M+111.9%
FY2019Dec 31, 2019$877.42K+7819.7%
FY2018Dec 31, 2018$11.08K-97.5%
FY2017Dec 31, 2017$449.37K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$26.69M+817.0%
Q1 FY2026Mar 31, 2026$6.71M+21.0%
Q4 FY2025Dec 31, 2025$7.80M+440.3%
Q3 FY2025Sep 30, 2025$7.18M+336.5%
Q2 FY2025Jun 30, 2025$2.91M+53.3%
Q1 FY2025Mar 31, 2025$5.55M+320.6%
Q4 FY2024Dec 31, 2024$1.44M-68.6%
Q3 FY2024Sep 30, 2024$1.65M-81.5%
Q2 FY2024Jun 30, 2024$1.90M-87.3%
Q1 FY2024Mar 31, 2024$1.32M-92.0%
Q4 FY2023Dec 31, 2023$4.60M-77.1%
Q3 FY2023Sep 30, 2023$8.90M-51.2%
Q2 FY2023Jun 30, 2023$14.97M-39.0%
Q1 FY2023Mar 31, 2023$16.51M-58.9%
Q4 FY2022Dec 31, 2022$20.05M-27.4%
Q3 FY2022Sep 30, 2022$18.25M-53.1%
Q2 FY2022Jun 30, 2022$24.55M+83.4%
Q1 FY2022Mar 31, 2022$40.20M+202.9%
Q4 FY2021Dec 31, 2021$27.61M+1384.9%
Q3 FY2021Sep 30, 2021$38.88M+2919.5%
Q2 FY2021Jun 30, 2021$13.39M+1244.0%
Q1 FY2021Mar 31, 2021$13.27M+16329.8%
Q4 FY2020Dec 31, 2020$1.86M+111.9%
Q3 FY2020Sep 30, 2020$1.29M+562.8%
Q2 FY2020Jun 30, 2020$995.99K+71348.0%
Q1 FY2020Mar 31, 2020$80.77K+4343.0%
Q4 FY2019Dec 31, 2019$877.42K+7819.7%
Q3 FY2019Sep 30, 2019$194.28K+152.0%
Q2 FY2019Jun 30, 2019$1.39K-99.0%
Q1 FY2019Mar 31, 2019$1.82K-99.3%
Q4 FY2018Dec 31, 2018$11.08K-97.5%
Q3 FY2018Sep 30, 2018$77.09K–
Q2 FY2018Jun 30, 2018$139.61K–
Q1 FY2018Mar 31, 2018$267.19K–
Q4 FY2017Dec 31, 2017$449.37K–
Q3 FY2017Sep 17, 2017$0–

More NRX Pharmaceuticals figures

See a number that looks wrong?